AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Barr Challenging Patent Protecting FemHrt Tablets.(Brief Article)
2002 JAN 10 - (NewsRx.com & NewsRx.net) -- Pfizer, Inc., has initiated a lawsuit against Barr Laboratories, Inc., for its challenge of the patent protecting Pfizer's FemHrt from generic competition. FemHrt is a continuous-combined HRT (CCHRT) indicated for women with an intact uterus for treatment of moderate to severe vasomotor symptoms associated with menopause and the prevention of osteoporosis. The product has annual sales of approximately $43 million, representing an increase of over 100% for the same period a year ago.
FemHrt is a tablet containing norethindrone acetate, 1 mg, and ethinyl estradiol, 5 mcg.
"The decision to pursue a generic FemHrt product complements our commitment to be a leading provider of female health care products, including hormonals and oral contraceptives, and is an important part of our overall business strategy," said Bruce L. Downey, Barr's chairman and CEO. "Through our recently completed merger with Duramed Pharmaceuticals, we have added the Cenestin (synthetic conjugated ...
- Barr Challenging Patent Protecting FemHrt(R) Tablets.
- Press release article from: PR Newswire December 12, 2001 700+ words
...which initiates Barr's challenge of the patent protecting Pfizer's FemHrt from generic competition. FemHrt is a continuous-combined HRT (CCHRT...percent for the same period a year ago. FemHrt is a tablet containing Norethindrone Acetate...
- Press Release: Barr challenging patent protecting FemHrt tablets.
- News wire article from: Chemical Business Newsbase December 12, 2001 700+ words
...which initiates Barr's challenge of the patent protecting Pfizer's FemHrt from generic competition. FemHrt is a continuous-combined HRT indicated...100% for the same period a year ago. FemHrt is a tablet containing norethindrone acetate...
- Activella and femhrt.(Drug overview)
- PDR Family Guide to Prescription Drugs January 22, 2007 700+ words
...brand name: Prefest Why is Activella and femhrt prescribed? These medications are designed...Most important fact about Activella and femhrt Because of the risk of uterine cancer...years. How should you take Activella and femhrt? Take one tablet at the same time each...
- Barr Receives Tentative Approval for Generic Version of Femhrt(R) Tablets.
- Press release article from: PR Newswire October 6, 2004 700+ words
...generic version of Warner Chilcott's Femhrt(R) (Norethindrone Acetate and Ethinyl...approval and launching its version of Femhrt in November 2009, six months prior to the expiration of the patent on Femhrt, under the terms of the April 2004...
- Warner Chilcott Announces Approval of Low-Dose femhrt(R) 0.5 mg/2.5 mcg.
- Press release article from: PR Newswire January 17, 2005 700+ words
...Administration (FDA) has approved low- dose femhrt(R) 0.5 mg/2.5 mcg for the treatment...half the dose of the currently marketed femhrt(R) 1 mg/5 mcg. The company expects to launch the new low-dose femhrt(R) 0.5 mg/2.5 mcg in the second...
- Barr receives tentative approval for generic version of Femhrt Tablets.
- News wire article from: Asia Africa Intelligence Wire October 6, 2004 700+ words
...generic version of Warner Chilcott's Femhrt (Norethindrone Acetate and Ethinyl Estradiol...approval and launching its version of Femhrt in Nov 2009, six months prior to the expiration of the patent on Femhrt, under the terms of the Apr 2004 agreement...
- Barr Announces Agreement with Galen Resolving Outstanding Patent Challenges on...
- Press release article from: PR Newswire April 27, 2004 700+ words
...Estrostep(R) oral contraceptive and femhrt(R) hormone therapy products. The agreement...will ensure Barr can bring alternative femhrt(R) and Estrostep(R) products to...license to launch a generic version of femhrt(R) in November 2009, six months prior...
- Warner Chilcott announces approval of low-dose femhrt 0.5 mg/2.5 mcg.
- News wire article from: Asia Africa Intelligence Wire January 17, 2005 700+ words
...Administration (FDA) has approved low-dose femhrt 0.5 mg/2.5 mcg for the treatment...half the dose of the currently marketed femhrt 1 mg/5 mcg. The company expects to launch the new low-dose femhrt 0.5 mg/2.5 mcg in 2Q 2005.
- Acquisition of women's healthcare products considered.(Galen Holdings PLC and...
- Magazine article from: Women's Health Weekly April 3, 2003 700+ words
...and the hormone replacement therapy, femhrt. The Pfizer Portfolio is being acquired...become payable in the event that both femhrt and Estrostep retain market exclusivity...Estrostep and Loestrin brand names and the femhrt hormone replacement therapy. * Total...
- Barr announces agreement with Galen resolving outstanding patent challenges on...
- News wire article from: Asia Africa Intelligence Wire April 27, 2004 700+ words
...s Estrostep oral contraceptive and femhrt hormone therapy products. The agreement...licence to launch a generic version of femhrt in Nov 2009, six months prior to the expiration of the patent on femhrt. As a result of the settlement, the...
Source: HighBeam Research, Barr Challenging Patent Protecting FemHrt Tablets.(Brief Article)